Diana Walleigh, MD

Publications

• Potter SN, Petzold C, Garbarini K, Forsythe AN, Jalazo E, Gable J, Zentz S, Okoniewski KC, Alperin S, Berry-Kravis E, Bird LM, Carson RP, de Wit MY, Heimer G, Le Pichon JB, Lindsey W, Lowden A, Makowski C, Marsh E, Myers KA, Nangia S, Nespeca M, Roche-Martínez A, Schleifer P, Sell E, Thibert R, Walleigh D, Moore A, Wheeler A. Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database. Pediatr Neurol. 2026 Sep;182:36-45. PubMed PMID: 42398223
• Ochenkowska K, Rampal B, Légaré A, Triassi V, Audet S, Brisson A, Bernas G, Liao M, da Silva Babinet A, Pilliod J, Gillaspie M, VanNoy GE, Pais L, O'Donnell-Luria A, Leclerc N, Walleigh D, Schmouth JF, Cappadocia L, Desrosiers P, De Koninck P, Tétreault M, Samarut É. Ultra-rare biallelic THAP12 variants cause loss of function and underlie severe epileptic encephalopathy. medRxiv. 2026 Mar 3. PubMed PMID: 41822681
• Shelkowitz E, Saneto RP, Al-Hertani W, Lubout CMA, Stence NV, Brown MS, Long P, Walleigh D, Nelson JA, Perez FE, Shaw DWW, Michl EJ, Van Hove JLK. Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels. Orphanet J Rare Dis. 2022 Dec 5;17(1):423. PubMed PMID: 36471344
• Joshi CN, Miller JS, Silveira LJ, Nelson JA, Walleigh DJ, Joshi SM, Patel AD. A Multicenter Study of Adherence to Best Practices and Application of Epilepsy Quality Metrics in a Pediatric Telemedicine Encounter. J Child Neurol. 2022 Aug;37(8-9):744-748. PubMed PMID: 35656770
• The impact of glycine reduction therapies on brain glycine levels in nonketotic hyperglycemia.
• Joshi CN, Chapman KE, Bear JJ, Wilson SB, Walleigh DJ, Scheuer ML. Semiautomated Spike Detection Software Persyst 13 Is Noninferior to Human Readers When Calculating the Spike-Wave Index in Electrical Status Epilepticus in Sleep. J Clin Neurophysiol. 2018 Sep;35(5):370-374. PubMed PMID: 29933261
• Current Diagnosis & Treatment Pediatrics
• Obudanersen, a UBE3A-ATS antisense oligonucleotide, for children and adults with Angelman syndrome: the HALOS phase 1-2a trial.

Professional Memberships

• American Epilepsy Society, Member
• Child Neurology Society, Member
• American Academy of Neurology, Member

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation

• Children's Hospital Colorado

Specialty Information

Specialties

• Child Neurology, Board Certification (2014)
• Epilepsy, Board Certification (2016)
• Pediatrics, Board Certification (2011)

Conditions & Treatments

• Brain and Nervous System
• Brain and Nervous System - Epilepsy